This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-small cell lung cancer, adenocarcinoma, helper endpoint
HLP_C3_NSCLC_ADENO
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2427 |
4. Check minimum number of eventsNone |
2427 |
5. Include endpointsNone |
2427 |
6. Filter based on genotype QC (FinnGen only) |
2337 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, adenocarcinoma, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, adenocarcinoma
- Non-small cell lung cancer
- Non-small cell lung cancer, including Hilmo
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of respiratory system and intrathoracic organs
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2337 | 920 | 1417 |
| Unadjusted period prevalence (%) | 0.52 | 0.33 | 0.65 |
| Median age at first event (years) | 70.60 | 69.45 | 71.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2427
- Matched controls
- 24270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
37.1
307.7
589
208
UGC12
NOMESCO Finland
Flexible bronchoscopy
11.8
307.7
990
1336
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
19.2
307.7
383
235
130
Kela drug reimbursment
Malignant tumour
21.0
307.7
1429
1548
GDC00
NOMESCO Finland
Lobectomy of lung
54.2
307.7
240
49
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
27.4
307.7
289
119
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
56.7
307.7
581
134
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
288.8
307.7
1096
69
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
33.4
307.7
255
85
L01CA04
ATC
vinorelbine; systemic
46.3
307.7
312
77
A03FA01
ATC
metoclopramide; systemic, rectal
6.0
307.7
1211
3471
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
307.7
920
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
232.9
307.7
686
41
Z51.5
ICD-10 Finland
Palliative care
6.3
307.7
691
1449
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
26.5
307.7
784
430
A04AA01
ATC
ondansetron; systemic, rectal
7.8
307.7
627
1032
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
32.7
307.7
385
139
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
86.4
307.7
474
68
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
18.9
307.7
1453
1778
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
27.1
307.7
231
94
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.2
307.7
499
739
H02AB02
ATC
dexamethasone; systemic
9.5
307.7
1014
1712
WF049
NOMESCO Finland
Radiotherapy of metastasis
14.0
307.7
519
461
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
307.7
856
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
267.1
307.7
420
19
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
307.7
539
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
22.9
305.8
227
109
WF004
NOMESCO Finland
Palliative radiotherapy
12.7
297.1
304
270
R84
ICPC
Malignant neoplasm bronchus/lung
52.2
295.6
170
35
N02AA05
ATC
oxycodone; systemic
4.6
291.2
1062
3508
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
20.2
284.6
223
121
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
306.0
246.6
247
9
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
14.5
234.7
218
164
JN4BD
NOMESCO Finland
Extensive body CT
4.7
225.1
659
1795
191
Kela drug reimbursment
Erlotinib
99.6
219.8
114
12
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
23.4
211.3
154
70
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
11.2
209.5
230
225
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
203.2
413
820
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.8
200.8
345
581
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.4
200.1
313
477
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
18.4
196.1
159
92
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
21.4
194.3
147
73
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
7.0
193.8
319
513
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
183.6
598
1743
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
179.3
675
2178
L01XE03
ATC
[U] erlotinib
80.0
159.2
85
11
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
58.0
149.4
84
15
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
29.9
143.1
95
33
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
136.1
1589
9541
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
7.6
135.6
200
283
WF002
NOMESCO Finland
Radical radiotherapy
4.6
132.9
352
864
155
Kela drug reimbursment
Afatinib and gefitinib
279.6
130.5
132
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.5
129.1
268
535
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
31.8
127.6
83
27
WZC30
NOMESCO Finland
Teaching
3.2
127.3
651
2495
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.7
126.1
251
482
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
19.2
124.3
98
53
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
18.4
123.0
99
56
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
221.4
122.9
126
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
122.9
744
3131
TGD00
NOMESCO Finland
Needle biopsy of lung
21.4
121.2
91
44
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.9
118.6
191
297
J93.8
ICD-10 Finland
Other pneumothorax
21.7
117.8
88
42
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.3
114.9
331
863
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
43.7
113.9
68
16
A04AA55
ATC
palonosetron, combinations; systemic
6.6
113.8
191
310
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.0
112.5
122
116
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
19.4
112.2
88
47
TGA30
NOMESCO Finland
Thoracocentesis
14.2
110.5
102
75
JN4AD
NOMESCO Finland
Body CT examination
3.3
107.2
483
1700
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
20.0
107.2
83
43
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
52.1
106.2
61
12
R03BB04
ATC
tiotropium bromide; inhalant
3.1
104.5
526
1975
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
48.1
104.4
61
13
ZX050
NOMESCO Finland
Stereotactic radiotherapy
12.8
104.0
102
83
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
5.7
103.9
205
389
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
20.1
103.8
80
41
1BA04, ,
NOMESCO Finland
529.9
103.4
102
*
A06AH03
ATC
naloxegol; oral
8.6
100.6
132
162
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
22.4
100.5
74
34
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.3
98.5
172
290
XX3DW
NOMESCO Finland
Time consuming IT work
3.1
97.8
475
1741
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
96.0
1010
5471
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.2
94.7
273
709
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
12.2
93.1
94
80
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
21.2
92.9
70
34
J94.8
ICD-10 Finland
Other specified pleural conditions
7.1
92.6
144
215
3004
Kela drug reimbursment
Osimertinib
448.5
87.7
87
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.0
86.2
267
729
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
30.1
84.7
56
19
1519, ,
Kela drug reimbursment
432.3
84.6
84
*
WX250
NOMESCO Finland
Intercostal blockade
31.2
84.1
55
18
A04AA02
ATC
granisetron; systemic, transdermal
3.7
83.2
296
889
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
20.8
83.0
63
31
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
6.6
82.8
136
215
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
81.2
328
1069
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
80.7
77
*
L01EB04
ATC
osimertinib; oral
410.8
80.4
80
*
B01AB05
ATC
enoxaparin; parenteral
2.2
77.0
1010
5877
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
45.8
76.1
45
10
N02AA01
ATC
morphine; systemic, rectal
5.8
74.0
139
251
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
72.8
270
831
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.9
72.5
101
133
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
250.7
71.7
73
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
7.3
71.4
107
153
341
Kela drug reimbursment
Afatinib and gefitinib
362.6
71.0
71
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
16.2
70.2
60
38
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
13.9
70.0
65
48
ZX120
NOMESCO Finland
Intravenous
2.9
69.3
373
1430
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
17.9
68.9
56
32
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
30.5
68.3
45
15
L01XE13
ATC
[U] afatinib
233.1
66.6
68
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
66.2
504
2297
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
65.9
776
4268
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.8
65.2
153
336
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
21.8
63.1
47
22
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
11.7
63.0
65
57
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
61.8
276
950
R4110
NOMESCO Finland
Physiotherapy
2.1
61.3
823
4737
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
61.1
955
5815
J01MA14
ATC
moxifloxacin; systemic
2.8
59.3
338
1331
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.2
57.5
121
242
N03AX16
ATC
[U] pregabalin
2.1
57.4
687
3769
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
56.7
184
516
H02AB06
ATC
prednisolone; systemic
2.0
56.7
1301
8989
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
8.4
56.6
74
90
A79
ICPC
Malignancy NOS
6.0
55.9
100
172
WX892
NOMESCO Finland
Monitored bed care
2.8
55.8
301
1149
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.7
55.2
104
188
J93.9
ICD-10 Finland
Pneumothorax, unspecified
14.2
54.5
50
36
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.3
54.1
146
358
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
53.5
216
698
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.3
52.5
107
208
M05BX04
ATC
denosumab; parenteral
3.0
52.4
250
891
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
14.5
52.0
47
33
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.9
51.3
157
422
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
7.6
51.0
73
99
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
14.8
50.3
45
31
A04AD12
ATC
aprepitant; systemic
5.7
50.0
95
173
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.3
49.7
203
660
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
48.6
206
685
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.9
48.2
108
228
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
10.0
48.1
55
56
N07BA03
ATC
varenicline; oral
4.1
48.1
138
354
GEA00
NOMESCO Finland
Mediastinoscopy
14.6
47.7
43
30
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.5
47.2
172
520
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.3
47.1
70
99
JN4CD
NOMESCO Finland
Very extensive body CT
3.4
47.0
176
542
B01AB10
ATC
tinzaparin; parenteral
2.5
46.5
333
1459
B03BA03
ATC
hydroxocobalamin; parenteral
2.8
46.4
253
968
J01MA12
ATC
levofloxacin; systemic
2.0
45.7
605
3405
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
8.9
44.1
55
63
L01XE02
ATC
[U] gefitinib
229.1
44.1
45
*
B01AB04
ATC
dalteparin; parenteral
3.1
43.6
195
668
1CD01, ,
NOMESCO Finland
14.8
42.5
38
26
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.5
41.2
59
80
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.9
40.8
63
93
Z2446
NOMESCO Finland
Social worker
2.9
40.6
201
729
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.5
40.4
52
62
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.7
39.7
228
894
N02AX02
ATC
tramadol; systemic, rectal
1.7
38.7
1142
8178
TGC00
NOMESCO Finland
Bronchial lavation
3.9
38.1
114
301
L01EB03
ATC
afatinib; oral
383.3
38.1
38
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.5
37.8
49
59
3001
Kela drug reimbursment
Alectinib
+∞
36.5
35
*
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.6
36.2
69
126
1504
Kela drug reimbursment
Alectinib
+∞
35.5
34
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.6
35.4
216
872
A98
ICPC
Health maint/preventive medicine
0.6
35.2
1731
19860
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
35.2
622
3810
GAC00
NOMESCO Finland
Biopsy of pleura
9.9
34.8
40
41
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
13.0
33.2
32
25
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
172.3
32.8
34
*
WW200, ,
SPAT
0.4
32.6
142
3579
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
32.2
506
2976
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
5.3
32.0
65
126
R03AC02
ATC
salbutamol; inhalant
1.7
31.9
1225
9244
R04.2
ICD-10 Finland
Haemoptysis
2.9
31.4
149
527
L01ED03
ATC
alectinib; oral
+∞
31.3
30
*
169
Kela drug reimbursment
Crizotinib
+∞
31.3
30
*
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.1
29.1
81
203
GDC10
NOMESCO Finland
Bilobectomy of lung
81.1
28.8
32
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
28.8
133
3282
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
5.2
28.6
59
116
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
28.3
322
1689
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.9
28.1
35
40
R06.0
ICD-10 Finland
Dyspnoea
1.7
27.3
738
5038
L03AA13
ATC
pegfilgrastim; parenteral
2.9
27.3
136
494
Z3231
NOMESCO Finland
Registered nurse
1.7
27.1
705
4766
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.7
26.9
62
134
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.4
26.6
96
288
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.4
26.3
200
893
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.5
26.0
64
146
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
25.8
946
6942
Z3226
NOMESCO Finland
Physiotherapist
1.8
25.0
473
2919
Z2221
NOMESCO Finland
Medical doctor
1.7
24.8
641
4307
L01XE16
ATC
[U] crizotinib
+∞
24.0
23
*
J86.9
ICD-10 Finland
Pyothorax without fistula
5.3
23.9
48
92
A02BC02
ATC
pantoprazole; systemic
1.6
23.4
1633
13737
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
23.4
894
6584
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
22.9
22
*
L01XE35
ATC
[U] osimertinib
232.1
22.7
23
*
N05CF01
ATC
zopiclone; oral
1.6
22.0
832
6091
L01EB01
ATC
gefitinib; oral
221.9
21.6
22
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
21.5
425
2645
SPAT1109
SPAT
Analgesia with portable analgesic pump
5.9
21.4
38
65
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
+∞
20.9
20
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
20.3
348
2078
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
6.0
20.0
35
59
N03AX14
ATC
levetiracetam; systemic
3.0
19.9
87
294
GDD00
NOMESCO Finland
Pneumonectomy
36.1
19.8
25
7
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.7
19.6
62
171
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.8
19.3
58
154
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
8.4
19.3
25
30
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.0
19.1
207
1063
P20
ICPC
Memory disturbance
0.5
19.1
143
2939
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
20.2
19.0
28
14
WX600
NOMESCO Finland
Single shot through catheter
4.9
19.0
41
84
ZX080
NOMESCO Finland
Image guided radiotherapy
3.1
18.9
79
260
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.3
18.8
150
683
L01XE36
ATC
[U] alectinib
+∞
18.8
18
*
363
Kela drug reimbursment
Crizotinib
+∞
18.8
18
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
18.5
126
535
ZXA00
NOMESCO Finland
Right side
1.5
18.4
692
5019
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
18.3
411
2638
ZXE00
NOMESCO Finland
One hour or less
1.5
18.3
874
6663
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
7.5
18.2
26
35
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
18.2
1066
8455
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.4
18.1
64
190
J43.9
ICD-10 Finland
Emphysema, unspecified
3.2
18.0
70
221
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
52.9
18.0
21
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
3.2
17.8
71
227
5826
FHL
Lobectomy or bilobectomy
16.7
17.8
28
17
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
13.8
17.7
30
22
OAB42, ,
SPAT
0.2
17.7
28
1251
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
17.4
84
300
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.1
17.4
26
37
WW500
NOMESCO Finland
Blood transfusion
2.4
17.3
122
526
R52.0
ICD-10 Finland
Acute pain
2.8
17.1
84
303
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
17.0
312
1896
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
22.0
16.8
24
11
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
16.7
16
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
5.8
16.7
30
52
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
15.1
16.6
27
18
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
7.3
16.5
24
33
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
16.5
348
5263
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
5.2
16.3
33
64
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
12.9
16.1
28
22
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
16.1
153
747
Z72.0
ICD-10 Finland
Tobacco use
3.1
16.0
65
211
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.3
15.9
124
559
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.7
15.9
36
77
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
14.6
15.8
26
18
C10AA07
ATC
rosuvastatin; oral
0.6
15.7
394
5730
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.2
15.6
61
193
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
14.8
15.3
25
17
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.6
15.3
246
4000
RS221, ,
NOMESCO Finland
3.9
15.2
44
114
PJD99
NOMESCO Finland
Excision of other lymph nodes
17.8
15.1
23
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
15.1
425
2876
A06AD11
ATC
lactulose; oral
1.6
15.0
434
2953
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
6.3
15.0
25
40
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
15.0
32
1194
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
14.0
15.0
25
18
N06DX01
ATC
memantine; oral
0.3
14.8
53
1498
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
11.4
14.8
27
24
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
25.2
14.7
20
8
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.2
14.7
39
95
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
150.9
14.5
15
*
R2110
NOMESCO Finland
Giving the first information
2.1
14.3
132
638
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
27.3
14.3
19
7
N06DA02
ATC
donepezil; oral
0.3
14.1
31
1135
N05BA06
ATC
lorazepam; systemic, sublingual
2.1
14.0
142
712
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
17.6
13.8
21
12
325
Kela drug reimbursment
Erlotinib
53.7
13.8
16
*
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
20.2
13.8
20
10
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.4
13.7
94
401
SFA20
NOMESCO Finland
Two-surface restoration
0.7
13.7
695
8850
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
13.6
351
2322
WX330
NOMESCO Finland
Paravertebral ansthesia
75.6
13.6
15
*
R85
ICPC
Malignant neopl respiratory other
12.1
13.6
24
20
WF099
NOMESCO Finland
Other radiotherapy
5.0
13.6
29
59
WW200
NOMESCO Finland
Immunization
2.8
13.5
65
233
R95
ICPC
Chron obstructive pulmonary disease
2.3
13.3
100
445
GDB10
NOMESCO Finland
Wedge resection of lung
13.9
13.2
22
16
JN6AD
NOMESCO Finland
CT of torso and neck
3.3
13.0
49
152
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
16.8
13.0
20
12
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
12.7
837
10245
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
12.6
455
3239
SFA10
NOMESCO Finland
One-surface restoration
0.7
12.5
670
8495
1CD02, ,
NOMESCO Finland
4.3
12.5
32
76
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
12.4
225
3562
EB1VA, ,
NOMESCO Finland
0.4
12.3
53
1377
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
12.2
70
275
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.6
12.1
28
61
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
12.0
296
1934
XX9XW, ,
NOMESCO Finland
5.3
12.0
24
46
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.7
11.9
27
58
GAA31
NOMESCO Finland
Thoracoscopy
9.0
11.7
24
27
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
11.6
389
5384
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
23.0
11.6
16
7
R03BB01
ATC
ipratropium bromide; inhalant
1.9
11.5
136
720
L01ED01
ATC
crizotinib; oral
+∞
11.5
11
*
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
120.6
11.4
12
*
C10AX09
ATC
ezetimibe; oral
0.6
11.4
161
2728
SDA03
NOMESCO Finland
Periodontal treatment
0.7
11.4
399
5478
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
11.3
502
3715
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
11.3
994
11724
SPAT1053
SPAT
Memory test
0.6
11.2
199
3174
S27.0
ICD-10 Finland
Traumatic pneumothorax
4.1
11.1
30
74
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
20.1
11.1
16
8
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.3
11.0
28
66
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
4.4
11.0
27
62
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
43.5
10.9
13
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
10.9
121
627
ZYC01, ,
SPAT
0.3
10.9
31
984
R03AC19
ATC
olodaterol
5.4
10.9
21
39
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
10.9
96
457
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
15.5
10.8
17
11
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.4
10.8
76
329
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
10.8
268
1754
SFA30
NOMESCO Finland
Three-surface restoration
0.7
10.8
502
6560
1BC05, ,
NOMESCO Finland
28.1
10.7
14
5
K02.1
ICD-10 Finland
Caries of dentine
0.7
10.7
723
8900
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
10.7
99
480
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
11.3
10.5
19
17
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
9.2
10.5
21
23
GDB20
NOMESCO Finland
Segmental resection of lung
+∞
10.4
10
*
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.5
10.4
65
267
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.5
10.3
71
1518
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.8
10.2
30
79
ZXD05
NOMESCO Finland
Urgent procedure
1.4
10.1
648
5093
WZC00, ,
SPAT
0.4
10.1
53
1261
A02BC01
ATC
omeprazole; systemic
1.4
10.0
628
4916
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.0
10.0
28
71
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
10.0
20
773
A10BK03
ATC
empagliflozin; oral
0.5
9.9
71
1498
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.2
9.9
38
120
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
20.1
9.8
14
7
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
20.1
9.8
14
7
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
4.7
9.8
22
47
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.0
9.7
102
519
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
55.2
9.6
11
*
N07BC02
ATC
methadone; systemic
7.8
9.6
21
27
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
8.4
9.5
20
24
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
9.5
522
6669
XG466
NOMESCO Finland
Sleep oxymetry
2.2
9.5
78
361
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
9.4
207
3149
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
9.4
96
483
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
30.1
9.4
12
*
L03AA02
ATC
filgrastim; parenteral
2.2
9.4
76
350
3017
Kela drug reimbursment
Brigatinib
+∞
9.4
9
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
21.8
9.3
13
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
9.2
781
6385
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.6
9.2
157
2541
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
9.2
35
963
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
9.2
131
738
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
7.7
9.1
20
26
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
8.3
9.1
19
23
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
9.0
463
5987
205
Kela drug reimbursment
Chronic hypertension
0.7
9.0
497
6352
H13
ICPC
Plugged feeling ear
0.7
8.9
246
3565
EB4VA, ,
NOMESCO Finland
0.3
8.8
32
899
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.3
8.8
32
98
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
3.3
8.8
32
98
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
8.7
18
681
Z01.2
ICD-10 Finland
Dental examination
0.7
8.7
510
6466
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
8.7
146
864
A10BK01
ATC
dapagliflozin; oral
0.4
8.7
37
963
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.6
8.6
204
3055
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.2
8.6
14
611
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
8.4
14
604
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.9
8.4
98
518
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.6
8.4
110
1907
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.8
8.3
120
679
WX402
NOMESCO Finland
General anaesthesia
1.4
8.3
387
2875
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
8.6
8.3
17
20
F03
ICD-10 Finland
Unspecified dementia
0.3
8.3
23
738
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
8.3
222
1478
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.1
8.3
22
54
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.2
8.2
32
102
L57.0
ICD-10 Finland
Actinic keratosis
0.6
8.2
123
2058
N05AD01
ATC
haloperidol; systemic
2.0
8.2
82
411
L17
ICPC
Foot/toe symptom/complaint
0.7
8.1
361
4795
B01AF01
ATC
rivaroxaban; oral
0.6
8.1
148
2355
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
8.1
80
399
L15
ICPC
Knee symptom/complaint
0.7
8.0
263
3688
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.5
8.0
26
74
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
4.3
7.9
20
47
SPAT1312
SPAT
General health counselling
0.7
7.9
383
5018
P70
ICPC
Dementia
0.2
7.9
9
407
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
13.1
7.9
13
10
SPAT1249
SPAT
Treatment-related counselling outside office
0.7
7.9
546
6773
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.2
7.8
14
576
D82
ICPC
Teeth/gum disease
0.7
7.8
363
4791
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.0
7.8
34
116
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.1
7.8
21
52
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
4.1
7.8
21
52
ZXA05
NOMESCO Finland
Left side
1.3
7.8
582
4657
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
7.0
7.8
18
26
OAB44, ,
SPAT
0.4
7.7
31
829
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.7
7.7
384
5011
M79.6
ICD-10 Finland
Pain in limb
0.8
7.7
559
6892
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
2.9
7.6
35
123
N05BA04
ATC
oxazepam; oral
1.3
7.6
526
4157
TQW40, ,
SPAT
0.4
7.6
41
965
SPAT1310
SPAT
Counselling related to known health issue
0.7
7.6
427
5469
A04AA03
ATC
tropisetron; systemic
6.7
7.6
18
27
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2.7
7.6
39
146
HA1AA
NOMESCO Finland
X-ray mammography
1.7
7.5
140
852
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
7.5
1262
14044
TDA90, ,
SPAT
0.3
7.5
24
716
R03AC18
ATC
indacaterol; inhalant
3.3
7.5
27
82
WZC30, ,
SPAT
0.3
7.5
24
714
H25.1
ICD-10 Finland
Senile nuclear cataract
0.8
7.5
518
6438
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.3
7.4
52
226
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
80.3
7.4
8
*
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
80.3
7.4
8
*
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
7.4
273
3751
UGB02
NOMESCO Finland
Tracheoscopy
13.4
7.4
12
9
R02
ICPC
Shortness of breath/dyspnoea
1.4
7.3
284
2038
L01ED04
ATC
brigatinib; oral
+∞
7.3
7
*
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
+∞
7.3
7
*
1521, ,
Kela drug reimbursment
+∞
7.3
7
*
L01EB02
ATC
erlotinib; oral
+∞
7.3
7
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
9.4
7.3
14
15
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.7
7.3
268
3684
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
7.3
111
640
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.0
7.2
31
105
N02AA03
ATC
hydromorphone; systemic, rectal
6.2
7.2
18
29
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.5
7.2
66
1278
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.6
7.2
101
1717
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
20.1
7.1
10
5
R50.9
ICD-10 Finland
Fever, unspecified
1.4
7.1
313
2301
ZXH06, ,
SPAT
0.3
7.1
15
556
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
7.0
53
238
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.9
7.0
20
52
A07AA02
ATC
nystatin; oral
1.7
7.0
134
824
L03AA14
ATC
lipegfilgrastim; parenteral
2.5
6.9
43
177
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.7
6.9
284
3834
N05AX08
ATC
risperidone; systemic
0.5
6.9
64
1234
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
6.9
39
899
J01AA02
ATC
doxycycline; systemic
1.3
6.9
1712
15818
G20
ICD-10 Finland
Parkinson disease
0.2
6.9
13
516
C09CA01
ATC
losartan; oral
0.7
6.9
381
4902
J96.1
ICD-10 Finland
Chronic respiratory failure
2.0
6.9
68
340
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.6
6.9
39
154
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.7
6.8
258
3535
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.5
6.8
23
67
G47.3
ICD-10 Finland
Sleep apnoea
0.7
6.8
253
3473
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
9.3
6.8
13
14
JN4DD
NOMESCO Finland
Scout CT scan of torso
9.3
6.8
13
14
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
6.8
129
2033
D19
ICPC
Teeth/gum symptom/complaint
0.7
6.8
261
3561
1XC18, ,
NOMESCO Finland
40.2
6.8
8
*
N40
ICD-10 Finland
Hyperplasia of prostate
0.8
6.7
459
5734
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
7.2
6.7
15
21
L13
ICPC
Hip symptom/complaint
0.7
6.7
224
3136
G04CB02
ATC
dutasteride; oral
0.6
6.7
105
1735
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
22.6
6.7
9
*
FE2AT
NOMESCO Finland
Pericardial cathetrisation with ultrasound guidance
22.6
6.7
9
*
OAA67, ,
SPAT
0.3
6.6
21
626
1240
FHL
Bronchoscopy
2.6
6.6
37
145
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.3
6.6
24
74
207
Kela drug reimbursment
Chronic arrhythmias
0.7
6.5
250
3419
R4110, ,
SPAT
0.5
6.5
64
1211
WZB00, ,
SPAT
0.4
6.5
26
695
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.0
6.5
*
161
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
6.5
151
2275
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.5
375
2881
GD6AD
NOMESCO Finland
CT of chest and neck
6.2
6.5
16
26
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.6
6.5
88
1510
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.8
6.4
645
7673
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
70.0
6.4
7
*
J98.4
ICD-10 Finland
Other disorders of lung
7.4
6.4
14
19
N04BD01
ATC
selegiline; oral
0.1
6.4
*
190
Z00.0
ICD-10 Finland
General medical examination
0.7
6.4
221
3076
T90
ICPC
Diabetes non-insulin dependent
0.7
6.4
361
4634
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.6
6.4
36
142
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.0
6.3
26
86
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.3
6.3
43
185
R03AC13
ATC
formoterol; inhalant
1.7
6.3
111
669
OAB43, ,
SPAT
0.5
6.3
52
1037
C79.49
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified parts of nervous system
+∞
6.3
6
*
3026
Kela drug reimbursment
Lorlatinib
+∞
6.3
6
*
L01ED05
ATC
lorlatinib; oral
+∞
6.3
6
*
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
2.3
6.2
46
205
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.6
6.2
86
1470
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
6.2
214
2983
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.9
6.2
27
93
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.2
6.2
11
449
WPB10
NOMESCO Finland
Making a convalescent care decision
5.3
6.1
17
32
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
6.1
170
1141
ZX114
NOMESCO Finland
Intramuscular
2.7
6.1
30
110
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
6.1
143
926
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.6
6.0
104
1677
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
445
501
10.65
307.65
1.4
1.5
—
—
—
0
0
436
291
18.04
307.65
1.1
1.1
—
—
—
0
0
443
822
6.37
235.47
2.1
2.6
—
—
—
0
0
297
364
9.16
229.41
1.4
1.5
39.16
31.41
g/l
16.50
281
331
793
2469
4.29
227.31
4.2
4.0
101.74
22.55
ug/l
2.65
733
2061
269
330
9.04
207.17
1.5
1.4
2694.08
1979.67
e6/l
0.71
199
230
251
298
9.28
198.19
1.5
1.4
64526.57
87218.97
e6/l
0.31
160
175
911
3479
3.59
188.91
4.5
3.1
0.79
0.82
mmol/l
9.36
884
3237
177
9
211.98
172.49
1.1
1.1
—
—
—
0
0
207
240
9.34
166.00
1.3
1.3
801.61
347.89
u/l
2.58
201
230
201
254
8.54
150.29
1.3
1.4
5.68
6.47
mmol/l
2.27
188
238
173
192
9.63
143.16
1.2
1.3
12.21
15.27
u/l
0.60
165
176
500
1654
3.55
123.84
5.4
2.1
418.63
368.71
nmol/l
5.25
486
1485
1461
8812
2.65
116.75
7.1
5.9
0.59
0.66
%
5.27
1427
8142
241
487
5.38
114.20
1.3
1.2
—
—
—
0
0
654
2720
2.92
108.64
4.3
4.1
255.97
246.72
u/l
0.66
640
2550
1470
9105
2.56
107.68
7.3
6.2
9.12
8.95
%
1.18
1438
8429
1466
9071
2.56
107.58
7.2
5.9
2.46
2.86
%
8.27
1434
8384
1480
9256
2.54
105.22
7.2
6.0
22.35
26.19
%
32.84
1448
8584
1680
11259
2.60
101.22
16.4
8.8
4.86
4.27
e9/l
14.10
1494
9767
139
181
8.09
100.91
1.3
1.4
10.35
13.82
u/l
6.65
130
171
1447
9109
2.46
99.01
7.0
5.8
62.12
58.40
%
23.87
1416
8446
1508
9818
2.42
93.42
7.2
5.6
1.83
1.89
e9/l
0.26
1317
8562
1520
9945
2.41
92.89
7.4
5.8
0.19
0.20
e9/l
0.59
1317
8601
730
3450
2.60
92.45
2.3
2.0
29.82
30.06
s
0.51
720
3339
950
5089
2.42
91.60
5.7
4.0
93.01
84.51
%
24.78
940
4966
1598
10805
2.40
88.79
11.9
6.3
9.60
12.20
umol/l
16.30
1569
10244
149
252
6.23
84.91
1.3
1.3
14.05
10.71
u/l
1.44
122
197
1567
10787
2.28
79.21
9.8
6.9
1.21
1.21
mmol/l
0.67
1372
9097
1471
9886
2.24
78.63
8.2
5.9
1.21
1.21
mmol/l
2.94
1415
8928
1560
10745
2.26
78.36
12.2
18.9
1.24
1.38
inr
5.77
320
3064
77
68
11.66
74.41
1.2
1.3
940.90
48.25
ug/l
3.16
66
30
79
77
10.57
71.44
1.2
1.4
3.95
3.46
mmol/l
0.51
74
69
774
4161
2.26
70.28
6.0
3.1
2.51
2.46
mmol/l
21.08
725
3651
116
185
6.53
69.93
1.2
1.3
—
—
—
0
0
1350
9317
2.01
60.48
6.3
4.8
32.81
34.66
g/l
24.06
1288
8611
1424
18006
0.49
59.37
3.8
4.8
1.41
1.44
mmol/l
1.61
1206
16129
1402
17768
0.50
57.58
5.6
6.6
40.69
40.90
mmol/mol
0.33
1204
16097
954
5904
2.01
57.47
4.5
3.2
30.68
36.94
u/l
2.58
923
5593
1455
18187
0.50
56.47
3.8
4.8
4.50
4.45
mmol/l
0.90
1238
16438
1096
7181
1.96
55.44
6.4
3.4
2.37
2.35
mmol/l
4.09
1027
6189
1527
18691
0.51
52.92
4.2
5.5
2.65
2.58
mmol/l
2.06
1285
16787
104
198
5.44
52.17
1.3
1.3
30.75
36.39
iu/l
0.77
84
166
60
63
9.74
51.38
1.3
1.3
19.00
23.94
%
0.54
53
48
307
1247
2.67
50.29
7.5
8.5
25.07
24.31
mmol/l
5.24
299
1204
1389
17434
0.52
50.25
3.5
4.3
1.30
1.28
mmol/l
0.63
1168
15460
71
106
6.87
45.49
1.2
1.5
62.75
67.39
%
0.46
62
85
805
5063
1.88
43.41
2.5
2.5
—
—
—
0
0
63
90
7.16
42.02
1.2
1.6
6.22
2.44
%
1.32
57
77
400
1980
2.22
41.89
6.3
6.4
1.17
1.40
mmol/l
5.76
386
1927
186
635
3.09
41.82
1.5
1.8
—
—
—
0
0
1571
12256
1.80
39.97
7.1
4.9
6.71
6.88
mmol/l
3.60
1527
11585
105
256
4.24
39.13
2.9
3.7
—
—
—
0
0
1164
8374
1.75
38.88
14.2
10.3
0.00
0.00
e9/l
0.22
912
6795
630
3795
1.89
37.96
1.9
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
220
869
2.68
37.74
2.3
2.9
0.36
0.35
u/ml
0.18
120
507
491
2739
1.99
37.07
6.7
6.7
5.26
5.09
kpa
3.48
462
2598
490
2740
1.99
36.71
6.7
6.7
1.39
1.15
mmol/l
0.89
417
2140
489
2739
1.98
36.43
6.7
6.7
11.44
11.85
kpa
0.99
458
2598
358
1809
2.15
35.19
2.7
2.4
32.54
37.97
u/l
0.85
315
1539
77
161
4.91
34.72
1.5
1.6
—
—
—
0
0
1574
18461
0.58
33.21
4.9
5.1
6.13
6.09
mmol/l
0.65
1350
16381
662
4330
1.73
29.08
4.6
4.0
356.06
605.63
ng/l
0.53
587
3729
274
5084
0.48
28.88
1.6
1.6
1.39
1.33
mmol/l
0.53
238
4163
114
374
3.15
27.36
1.4
1.7
3.47
4.36
iu/l
0.40
12
120
443
2643
1.83
26.39
1.9
1.8
—
—
—
0
0
440
2632
1.82
25.94
1.9
1.8
—
—
—
0
0
364
2072
1.89
25.07
1.7
2.7
64.11
66.25
g/l
5.65
338
1884
107
364
3.03
24.14
1.5
1.4
—
—
—
0
0
93
294
3.25
23.74
1.5
1.4
—
—
—
0
0
270
1426
2.01
23.10
4.2
3.6
2.44
1.89
mmol/l
1.54
225
1045
90
287
3.22
22.66
1.4
1.4
—
—
—
0
0
124
474
2.70
22.58
1.2
1.4
—
—
—
0
0
124
474
2.70
22.58
1.2
1.4
—
—
—
0
0
106
374
2.92
22.43
1.4
1.7
—
—
—
0
0
278
1507
1.95
22.04
4.4
3.7
5.19
5.14
kpa
0.37
266
1422
454
6796
0.59
21.92
2.8
3.2
7.20
7.22
mmol/l
0.04
355
5617
96
325
3.03
21.86
1.4
1.4
—
—
—
0
0
211
1041
2.12
21.67
1.8
1.9
3.00
2.71
ug/l
0.08
190
904
126
500
2.60
21.31
1.5
1.6
—
—
—
0
0
243
1272
2.01
21.27
8.9
9.2
—
—
—
0
0
485
7084
0.61
20.97
3.4
3.8
12.78
8.86
mg/mmol
0.80
318
4514
1782
15454
1.58
20.89
16.8
7.8
88.68
80.94
u/l
8.34
1753
14454
811
5975
1.54
20.54
3.2
3.4
0.56
0.48
e6/l
0.40
626
4648
400
2478
1.74
20.53
7.5
7.0
94.75
95.25
%
0.84
385
2377
176
828
2.21
20.37
1.9
2.2
263.24
795.42
ug/l
1.38
159
780
455
6706
0.60
20.24
2.9
3.3
532.79
275.76
mg/l
0.56
306
4334
127
524
2.50
19.82
2.2
2.1
120.66
127.98
g/l
1.77
64
375
127
526
2.49
19.66
1.4
1.6
—
—
—
0
0
53
132
4.08
19.27
1.1
1.2
—
—
—
0
0
868
6561
1.50
19.15
3.3
3.5
51.64
96.90
e6/l
1.74
673
5151
1849
20249
0.64
18.60
43.2
25.4
126.09
133.29
g/l
79.72
1815
19842
1849
20246
0.64
18.53
42.9
25.3
4.24
4.40
e12/l
36.74
1782
19520
1849
20242
0.64
18.43
43.0
25.3
272.06
240.01
e9/l
55.80
1792
19603
509
3445
1.60
18.38
2.9
3.2
1.98
1.86
e6/l
0.16
285
1951
1850
20246
0.64
18.33
43.0
25.3
8.07
6.86
e9/l
34.69
1780
19521
29
44
6.66
18.31
1.2
1.6
14.90
3.88
%
1.63
20
24
1849
20236
0.64
18.29
43.6
25.4
38.21
39.44
%
17.45
1725
18615
362
2256
1.71
18.02
7.9
7.4
120.22
120.51
g/l
0.11
350
2192
30
48
6.32
18.02
1.2
1.1
2.07
1.54
mmol/l
1.38
24
31
683
8974
0.67
17.15
4.8
5.5
2.43
4.18
ug/l
2.84
586
7908
519
7208
0.64
17.06
4.0
4.7
19.68
22.00
%
3.38
270
3849
842
6440
1.47
17.02
4.6
2.5
61.71
72.51
u/l
0.40
803
5898
1507
17045
0.69
15.90
5.9
4.7
1.93
2.11
mu/l
1.42
1329
15152
600
7890
0.68
14.32
2.0
2.2
76.98
79.16
nmol/l
0.96
524
6834
927
7420
1.40
13.87
3.8
4.0
82.32
119.26
e6/l
0.54
689
5479
1133
9392
1.39
13.71
2.7
2.7
—
—
—
0
0
44
123
3.62
13.69
1.6
1.5
—
—
—
0
0
510
3667
1.49
13.54
2.8
3.0
1.08
1.10
e6/l
0.05
287
2160
32
71
4.55
13.53
1.2
1.5
—
—
—
0
0
34
80
4.30
13.37
1.1
1.9
—
—
—
0
0
34
80
4.30
13.37
1.1
1.9
—
—
—
0
0
266
1649
1.69
13.33
3.2
4.1
0.17
0.10
%
0.77
149
558
48
145
3.36
13.29
1.6
1.4
—
—
—
0
0
1819
19713
0.69
12.98
20.8
11.4
24.78
25.14
u/l
0.43
1783
18804
34
82
4.19
12.96
1.1
1.8
—
—
—
0
0
43
123
3.54
12.94
1.7
1.5
—
—
—
0
0
239
1451
1.72
12.93
1.8
1.7
—
—
—
0
0
255
1579
1.69
12.83
3.2
3.9
0.77
0.70
%
0.29
146
562
77
309
2.54
12.82
1.6
1.6
—
—
—
0
0
257
1603
1.67
12.57
1.5
1.6
—
—
—
0
0
61
221
2.81
12.41
1.3
1.6
—
—
—
0
0
734
9151
0.72
12.34
2.0
2.1
90.03
93.32
pmol/l
1.18
361
4728
58
208
2.83
12.04
1.3
1.6
—
—
—
0
0
1840
19840
0.70
11.93
32.8
20.5
4.01
4.00
mmol/l
0.28
1798
19265
542
4035
1.44
11.85
1.7
1.7
2.26
1.50
mg/l
1.92
456
3165
109
531
2.10
11.60
4.4
5.0
3.19
2.68
mmol/l
0.87
86
364
157
869
1.86
11.60
2.8
3.3
741.34
5028.56
u/ml
0.74
134
745
338
4807
0.66
11.51
1.5
1.7
479.73
21565509.56
pmol/l
3.08
261
3872
87
389
2.28
11.45
2.0
3.7
1.61
1.65
%
0.04
82
340
1840
19806
0.71
11.35
32.7
20.3
138.34
139.64
mmol/l
58.27
1804
19264
333
2269
1.54
11.25
2.7
2.7
7.75
9.58
umol/l
0.61
293
2017
53
190
2.83
11.03
1.3
1.6
—
—
—
0
0
53
190
2.83
11.03
1.3
1.6
—
—
—
0
0
53
190
2.83
11.03
1.3
1.6
—
—
—
0
0
62
244
2.58
10.79
1.6
1.6
—
—
—
0
0
79
348
2.31
10.78
1.3
1.6
—
—
—
0
0
79
348
2.31
10.78
1.3
1.6
—
—
—
0
0
215
1337
1.67
10.62
1.5
1.5
—
—
—
0
0
82
371
2.25
10.52
3.8
3.3
60.70
58.92
%
0.50
82
371
296
4256
0.65
10.51
3.9
4.4
1.02
1.02
kg/l
0.19
44
672
158
904
1.80
10.50
5.0
3.9
25.65
24.78
mmol/l
2.52
151
835
99
484
2.09
10.47
2.0
2.3
222.57
204.12
%
1.33
92
459
92
438
2.14
10.42
1.3
1.7
—
—
—
0
0
568
7234
0.72
10.36
4.0
4.3
—
—
—
0
0
79
356
2.26
10.24
3.3
3.1
4.79
4.42
e9/l
0.59
79
356
24
54
4.48
10.02
1.0
1.2
—
—
—
0
0
49
184
2.70
9.39
1.6
1.6
—
—
—
0
0
35
109
3.24
9.31
1.1
1.7
—
—
—
0
0
35
109
3.24
9.31
1.1
1.7
—
—
—
0
0
400
5308
0.70
9.11
4.1
4.3
0.00
0.00
estimate
0.50
155
1693
180
2801
0.61
9.02
10.4
7.7
—
—
—
0
0
161
973
1.70
8.87
1.8
2.0
—
—
—
0
0
98
514
1.94
8.59
2.9
2.5
14.77
15.86
%
1.52
53
259
788
6619
1.28
7.24
2.5
2.2
149.39
235.50
u/l
3.87
763
6164
107
1793
0.58
7.18
1.4
1.3
—
—
—
0
0
295
2142
1.43
7.16
3.3
3.5
2.21
2.04
mmol/l
0.35
256
1762
295
2153
1.42
6.96
3.3
3.5
5.84
5.84
kpa
0.01
286
2082
431
5443
0.75
6.86
1.5
1.6
19.90
20.17
nmol/l
0.15
374
4557
1250
13848
0.80
6.80
5.2
3.9
15.34
15.08
pmol/l
2.65
1130
12234
17
28
6.11
6.76
1.2
1.2
—
—
—
0
0
813
9443
0.79
6.71
4.9
5.3
0.00
0.00
estimate
-0.00
179
1802
826
9573
0.79
6.68
3.6
4.0
0.00
0.01
estimate
1.08
170
1751
72
372
1.96
6.66
4.4
5.3
427.20
750.30
iu/ml
—
10
53
817
9464
0.79
6.53
3.5
4.0
0.00
0.00
estimate
1.15
184
1940
402
5088
0.75
6.44
3.1
3.3
0.79
0.82
ug/l
0.20
284
3663
73
386
1.92
6.33
1.7
2.0
1.57
1.68
mmol/l
0.58
73
374
569
4675
1.28
6.06
2.6
2.7
5.54
4.67
e6/l
0.84
513
4211
138
895
1.57
5.83
1.6
1.9
—
—
—
0
0
835
7244
1.23
5.45
3.0
3.2
1398.63
1772.54
ng/l
2.17
756
6290
19
57
3.35
5.44
1.2
1.9
—
—
—
0
0
14
25
5.63
5.37
1.1
1.0
48.80
7.50
iu/ml
—
5
10
249
1851
1.38
5.28
5.7
3.9
1.22
1.22
mmol/l
0.14
237
1607
135
895
1.54
5.20
1.1
1.1
191.40
142.35
iu/ml
0.32
16
310
265
3458
0.74
5.13
1.2
1.2
2.55
1.60
u/ml
0.38
52
848
16
38
4.23
4.82
1.1
1.2
—
—
—
0
0
369
2958
1.29
4.68
4.2
5.6
1.02
1.03
mmol/l
0.37
348
2729
30
127
2.38
4.65
1.2
1.2
290.00
121.25
titre
—
7
24
1672
17698
0.82
4.61
30.1
16.3
76.75
73.26
ml/min/173m2
10.72
1517
14690
461
5522
0.80
4.59
2.7
2.9
5649.11
6336.74
umol/l
0.11
386
4707
30
130
2.32
4.43
2.8
3.5
—
—
—
0
0
28
120
2.35
4.25
1.6
1.7
—
—
—
0
0
31
142
2.20
4.05
1.2
1.3
—
—
—
0
0
210
2726
0.75
3.91
3.3
4.8
32.27
33.19
%
0.60
136
1757
388
4658
0.80
3.87
1.8
1.8
1056.27
1180.68
nmol/l
1.66
278
3456
135
957
1.43
3.82
3.2
3.2
4.19
4.34
pmol/l
1.02
126
824
268
2122
1.30
3.74
4.8
7.0
8.81
11.05
mmol/l
6.46
252
2006
228
1766
1.32
3.74
3.2
2.8
4.50
4.48
kpa
0.04
223
1701
20
78
2.58
3.71
1.2
1.1
—
—
—
0
0
26
117
2.24
3.57
1.5
1.5
5.07
6.65
u/l
0.32
21
97
44
241
1.84
3.57
1.5
1.5
—
—
—
0
0
44
241
1.84
3.57
1.5
1.5
—
—
—
0
0
226
2851
0.77
3.41
1.2
1.3
36.67
40.16
iu/ml
0.17
84
905
50
830
0.59
3.36
1.7
1.8
—
—
—
0
0
685
7689
0.85
3.29
2.6
2.8
251.85
160.78
ug/l
5.25
622
6914
23
102
2.27
3.29
1.4
1.4
—
—
—
0
0
23
102
2.27
3.29
1.4
1.4
—
—
—
0
0
218
2733
0.78
3.14
1.2
1.2
48.22
13.27
u/ml
0.80
65
977
9
20
4.51
3.11
1.4
1.2
—
—
—
0
0
372
3130
1.22
3.09
2.2
2.6
20.11
22.17
%
1.49
343
2657
23
462
0.49
2.99
2.1
1.7
4.20
3.85
mg/l
0.06
23
363
38
220
1.74
2.65
1.2
1.3
270.87
275.83
mosm/kgh2o
0.85
32
160
107
788
1.37
2.53
1.8
1.7
37.79
38.12
u/l
0.06
91
668
382
3289
1.19
2.50
2.1
2.5
2.15
2.27
g/l
3.40
360
3034
142
1819
0.77
2.45
2.0
2.1
178.86
160.79
ug/g
0.17
113
1415
26
138
1.89
2.41
1.4
1.3
—
—
—
0
0
47
725
0.64
2.40
1.0
1.0
—
—
—
0
0
23
117
1.98
2.40
1.4
2.0
—
—
—
0
0
26
139
1.88
2.36
1.4
1.3
—
—
—
0
0
70
486
1.45
2.33
1.6
1.8
11.79
12.21
mg/l
0.19
65
441
11
262
0.42
2.32
1.3
1.4
—
—
—
0
0
20
99
2.03
2.26
1.0
1.0
—
—
—
0
0
95
706
1.36
2.17
1.3
1.2
—
—
—
0
0
19
357
0.53
2.10
1.5
1.3
—
—
—
0
0
403
3540
1.17
2.09
2.2
2.5
10.71
12.37
umol/l
3.67
381
3288
243
2063
1.20
1.89
2.0
2.1
0.20
0.20
g/l
0.26
223
1913
17
86
1.98
1.85
1.3
1.2
—
—
—
0
0
14
67
2.10
1.76
1.2
1.5
—
—
—
0
0
273
3144
0.85
1.75
1.5
1.5
2.39
2.72
g/l
2.04
143
1799
903
8445
1.11
1.73
4.4
4.1
31.02
64.49
ng/l
3.07
742
6565
0
47
0.00
1.70
0.0
1.4
—
—
—
0
0
327
2874
1.16
1.70
2.2
2.4
1.82
1.80
%
0.20
294
2518
1498
15560
0.90
1.69
38.0
20.2
14.93
15.44
%
5.23
1482
15237
182
1523
1.21
1.68
6.9
6.6
25.32
24.51
mmol/l
2.69
169
1444
69
513
1.36
1.64
1.3
1.6
125.17
14.26
iu/ml
0.41
23
106
11
49
2.25
1.63
1.3
1.6
86.18
204.88
nmol/24h
0.43
11
49
33
213
1.56
1.62
1.2
1.2
2.38
3.31
u/ml
—
8
68
0
44
0.00
1.51
0.0
2.0
—
1.20
—
0
44
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
5
126
0.40
1.49
1.6
1.7
93.20
93.76
umol/l
—
5
126
65
489
1.34
1.46
1.5
1.5
0.24
0.24
g/l
0.05
58
468
12
227
0.53
1.43
1.5
1.5
—
—
—
0
0
43
600
0.71
1.42
1.3
1.4
—
—
—
0
0
93
1158
0.80
1.38
2.5
2.5
14.24
22.45
au/ml
—
8
59
1487
14356
1.09
1.35
4.8
4.2
20.17
14.20
mm/h
22.52
1405
13105
62
475
1.31
1.26
1.4
2.5
30.91
33.97
umol/l
0.84
53
428
30
205
1.47
1.20
1.2
1.2
2.22
6.28
u/ml
—
9
93
142
1662
0.85
1.17
5.0
2.8
61.02
59.86
ml/min/173m2
0.17
64
710
0
35
0.00
1.15
0.0
1.7
—
138.95
—
0
35
65
510
1.28
1.14
1.6
1.5
1.09
1.18
g/l
1.46
59
489
247
2198
1.14
1.13
2.7
3.0
226.71
233.90
ng/l
0.08
222
2011
85
1037
0.81
1.10
1.3
1.3
66.33
59.48
au/ml
—
6
63
10
181
0.55
1.08
1.2
1.2
0.96
1.50
nmol/l
—
10
158
7
32
2.19
1.08
1.0
1.2
—
—
—
0
0
5
22
2.28
1.03
1.8
1.4
—
—
—
0
0
18
114
1.58
1.02
1.6
2.1
429.00
660.36
e6/l
1.50
18
108
34
460
0.74
1.00
1.7
1.6
—
—
—
0
0
84
692
1.22
1.00
1.8
2.5
0.00
0.00
g/l
-0.00
75
645
85
702
1.22
0.99
1.8
2.5
0.00
0.00
g/l
-0.00
75
646
157
1371
1.16
0.97
1.9
2.1
8.22
12.04
nmol/l
7.29
131
1181
0
30
0.00
0.97
0.0
2.3
—
—
—
0
0
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
0
31
0.00
0.96
0.0
2.3
—
—
—
0
0
41
312
1.32
0.93
3.3
2.4
4.16
4.10
mmol/l
0.41
41
307
41
312
1.32
0.93
3.3
2.4
104.61
105.30
mmol/l
0.36
41
307
27
195
1.39
0.86
1.1
1.1
—
—
—
0
0
10
57
1.76
0.83
1.7
2.1
—
—
—
0
0
17
114
1.49
0.79
2.0
2.7
39.43
39.39
%
—
7
73
27
362
0.74
0.79
1.4
1.7
46.37
45.78
nmol/l
0.04
27
342
42
330
1.28
0.79
1.2
1.2
—
—
—
0
0
5
97
0.51
0.78
1.0
1.1
—
—
—
0
0
239
2180
1.11
0.77
2.4
2.5
73.92
68.67
e9/l
1.05
144
1689
47
583
0.80
0.77
2.1
2.2
89.96
89.48
ug/min
0.01
29
346
19
266
0.71
0.73
1.7
1.8
160.16
200.12
pmol/l
1.67
19
245
34
435
0.78
0.73
1.1
1.4
—
—
—
0
0
842
8752
0.94
0.73
2.5
2.2
—
—
—
0
0
19
265
0.71
0.72
1.1
1.1
1.20
88.23
iu/ml
—
5
46
538
5669
0.93
0.71
2.2
2.2
3.33
3.06
mg/l
1.35
451
4765
86
739
1.17
0.71
1.9
2.5
0.04
0.02
g/l
0.36
76
680
141
1579
0.89
0.70
1.7
1.7
1.68
1.62
%
0.29
118
1314
11
69
1.60
0.68
1.3
1.2
232.41
256.92
iu/ml
0.08
11
69
33
258
1.28
0.67
1.4
1.4
—
—
—
0
0
33
258
1.28
0.67
1.4
1.4
—
—
—
0
0
1367
13351
1.05
0.65
4.7
4.9
312.83
2417.57
e6/l
2.31
18
232
53
440
1.21
0.65
1.5
1.4
—
—
—
0
0
44
537
0.82
0.65
1.4
1.6
24121.27
15095.22
e6/l
0.36
33
385
1838
18648
0.94
0.64
32.4
17.1
36.51
26.99
mg/l
24.55
1755
15186
33
260
1.27
0.64
1.4
1.4
—
—
—
0
0
24
312
0.77
0.61
1.1
1.1
—
—
—
0
0
15
210
0.71
0.60
1.3
1.3
571367.80
130177.46
e6/l
—
10
144
17
122
1.40
0.60
1.6
3.6
—
—
—
0
0
52
617
0.84
0.59
1.4
1.5
—
—
—
0
0
199
2161
0.91
0.59
2.1
2.5
4.45
7.55
ug/l
4.28
173
1864
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
68
586
1.17
0.57
1.2
1.2
0.40
1.17
u/ml
—
5
52
32
397
0.80
0.57
1.2
1.4
0.94
0.83
nmol/l
0.25
24
313
42
347
1.21
0.56
1.2
1.4
—
—
—
0
0
29
230
1.26
0.55
3.2
2.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
107
1.40
0.55
1.1
1.1
—
—
—
0
0
51
601
0.85
0.55
1.3
1.5
315.67
271.19
ug/g
0.76
29
369
36
294
1.23
0.54
1.8
2.5
140.00
1415.59
u/ml
—
5
27
6
39
1.54
0.53
1.0
1.3
—
—
—
0
0
6
98
0.61
0.52
1.2
1.1
—
—
—
0
0
32
261
1.23
0.49
1.4
1.4
—
—
—
0
0
32
388
0.82
0.48
1.2
1.3
—
—
—
0
0
65
569
1.15
0.47
3.5
3.2
0.84
0.84
nmol/l
0.02
50
433
32
263
1.22
0.47
1.4
1.4
—
—
—
0
0
42
355
1.19
0.47
1.0
1.1
—
—
—
0
0
87
778
1.12
0.46
1.8
2.4
36.71
37.30
g/l
0.38
76
685
18
230
0.78
0.43
1.0
1.0
—
—
—
0
0
14
104
1.35
0.43
1.1
1.1
—
—
—
0
0
14
104
1.35
0.43
1.1
1.5
24.93
6.33
u/l
—
9
88
12
87
1.38
0.42
1.1
1.0
0.97
1.29
u/l
—
7
47
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
0.13
—
0
6
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
4.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
58
511
1.14
0.40
5.1
3.2
7.79
7.69
mmol/l
0.13
58
495
31
259
1.20
0.40
1.4
1.4
—
—
—
0
0
11
149
0.74
0.40
1.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
33
387
0.85
0.37
1.2
1.3
86.32
598.42
e6/l
1.09
19
322
33
387
0.85
0.37
1.2
1.3
5.84
34.26
e6/l
1.14
19
308
42
482
0.87
0.37
1.2
1.4
—
—
—
0
0
108
995
1.09
0.36
5.9
4.8
1.69
1.62
%
0.37
96
931
59
527
1.12
0.35
1.1
1.2
—
—
—
0
0
6
86
0.70
0.33
3.5
4.1
14.03
13.37
%
—
6
86
59
534
1.11
0.29
1.1
1.2
—
—
—
0
0
15
121
1.24
0.28
1.1
1.1
—
—
—
0
0
15
121
1.24
0.28
1.1
1.1
—
—
—
0
0
34
298
1.14
0.28
1.4
1.5
185.15
281.39
pmol/l
0.56
34
293
8
62
1.29
0.28
1.3
1.1
—
—
—
0
0
9
116
0.78
0.27
1.0
1.4
—
—
—
0
0
63
688
0.91
0.27
1.1
1.2
—
—
—
0
0
15
122
1.23
0.27
1.1
1.1
—
—
—
0
0
15
122
1.23
0.27
1.1
1.1
—
—
—
0
0
15
122
1.23
0.27
1.1
1.1
—
—
—
0
0
1092
11082
0.97
0.27
5.2
3.2
69.39
56.75
u/l
2.17
1006
10053
125
1177
1.07
0.26
1.6
1.7
1.91
1.52
g/l
3.04
107
1004
59
539
1.10
0.26
7.0
6.5
103.29
105.47
mmol/l
2.80
48
480
11
86
1.28
0.26
1.5
2.3
744.64
1404.36
u/ml
1.04
11
86
5
71
0.70
0.26
1.0
1.3
—
—
—
0
0
5
74
0.68
0.26
4.2
4.5
—
35.54
—
0
13
23
267
0.86
0.25
1.1
1.2
235.71
304.65
u/ml
0.91
14
151
56
511
1.10
0.25
1.8
3.3
125.84
1098.03
u/ml
1.09
49
472
9
74
1.22
0.25
1.1
1.1
—
525.28
ng/l
—
0
21
14
114
1.23
0.25
1.5
2.0
—
—
—
0
0
90
841
1.07
0.24
1.9
2.7
1.32
1.23
g/l
0.06
74
727
44
486
0.90
0.24
3.9
3.7
34.96
28.91
mg/l
0.33
29
304
99
931
1.07
0.23
1.9
2.5
10.75
10.39
g/l
0.30
86
832
12
97
1.24
0.23
1.6
3.4
202.17
215.14
u/l
0.36
12
97
95
893
1.07
0.22
1.2
1.3
322.42
226.03
u/ml
0.45
83
809
7
92
0.76
0.22
1.4
1.7
12.57
15.68
nmol/l
—
7
82
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
9.76
—
0
14
12
100
1.20
0.18
1.1
1.3
—
—
—
0
0
34
372
0.91
0.17
1.5
1.6
—
—
—
0
0
148
1424
1.04
0.17
2.0
2.8
10.02
10.71
g/l
1.42
137
1289
13
151
0.86
0.15
1.0
1.0
—
—
—
0
0
8
73
1.10
0.15
1.3
1.4
1.37
1.57
g/l
—
8
73
6
79
0.76
0.15
1.0
1.2
—
75.18
%
—
0
11
10
83
1.21
0.15
1.1
1.2
—
—
—
0
0
9
80
1.13
0.15
1.6
2.4
—
—
—
0
0
9
80
1.13
0.15
1.6
2.4
—
—
—
0
0
26
286
0.91
0.15
1.1
1.2
—
—
—
0
0
179
1845
0.97
0.14
1.2
1.3
—
—
—
0
0
29
316
0.92
0.14
1.2
1.2
86.40
52.82
u/ml
—
5
31
164
1691
0.97
0.14
2.6
3.9
83.27
95.70
ng/l
1.42
149
1451
12
103
1.17
0.13
1.8
1.6
0.97
0.97
g/l
0.01
12
103
30
276
1.09
0.13
1.1
1.4
189.00
125.61
u/ml
—
9
50
9
108
0.83
0.13
1.2
1.2
7.07
10.19
mmol/l
—
9
101
16
142
1.13
0.12
2.1
2.3
—
—
—
0
0
13
148
0.88
0.12
1.1
1.1
—
—
—
0
0
10
85
1.18
0.12
1.1
1.2
—
—
—
0
0
109
1052
1.04
0.12
3.0
2.4
0.63
0.64
%
0.17
109
1044
24
220
1.09
0.11
1.1
1.3
313.50
270.43
pmol/l
0.38
24
186
86
828
1.04
0.11
2.7
3.5
39.99
74.33
mg/l
1.16
65
679
86
828
1.04
0.11
2.7
3.5
40.71
60.10
mg/l
1.56
62
676
95
917
1.04
0.11
1.9
2.6
3.33
3.01
g/l
2.90
84
824
240
2354
1.02
0.10
4.8
3.7
—
—
—
0
0
27
251
1.08
0.10
1.2
1.4
—
—
—
0
0
14
125
1.12
0.10
1.1
1.1
—
—
—
0
0
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
17
186
0.91
0.09
1.1
1.3
—
—
—
0
0
36
341
1.06
0.08
1.6
1.9
4.66
4.70
mmol/24h
0.02
30
293
111
1081
1.03
0.08
5.5
3.7
46.97
47.56
%
0.09
111
1066
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
6
72
0.83
0.07
1.0
1.0
—
—
—
0
0
16
147
1.09
0.07
1.0
1.1
—
—
—
0
0
51
525
0.97
0.05
1.6
1.6
—
—
—
0
0
11
120
0.92
0.05
2.1
2.4
—
—
—
0
0
100
983
1.02
0.04
1.9
2.5
3.73
3.69
g/l
0.12
88
891
11
101
1.09
0.04
1.0
1.0
—
—
—
0
0
100
984
1.02
0.04
1.9
2.5
—
—
—
0
0
17
180
0.94
0.04
1.0
1.1
—
—
—
0
0
100
985
1.02
0.03
1.9
2.5
7.86
7.42
g/l
1.47
88
892
17
164
1.04
0.00
1.1
1.1
—
68.29
—
0
7
19
191
0.99
0.00
1.6
1.8
3.94
4.60
mg/l
0.43
19
184
48
475
1.01
0.00
1.2
1.2
22.20
24.79
u/ml
—
5
25
114
1135
1.00
0.00
1.8
1.9
2.13
1.50
g/l
0.65
106
1019
19
186
1.02
0.00
1.0
1.1
—
—
—
0
0
41
414
0.99
0.00
1.1
1.3
—
238.57
—
0
14
46
457
1.01
0.00
1.2
1.2
9.71
6.92
u/ml
—
7
72
12
123
0.98
0.00
2.0
1.3
—
—
—
0
0
12
123
0.98
0.00
2.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.10
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
19
190
1.00
-0.00
1.8
2.2
614.00
640.45
ml
0.07
12
120
0
8
0.00
-0.00
0.0
1.1
—
7.56
—
0
8
45
450
1.00
-0.00
1.1
1.2
3.20
3.77
u/ml
—
5
46
9
91
0.99
-0.00
1.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.0
—
385.33
—
0
6
0
6
0.00
-0.00
0.0
6.8
—
67.00
—
0
6
6
68
0.88
-0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_NSCLC_ADENO – Non-small cell lung cancer, adenocarcinoma, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).